参考文献:1.V. M. Koval’zon, “The brain and sleep: from neurons to molecules,” Zh. Vyssh. Nerv. Deyat., 73, No. 1, 48–70 (2013). 2.V. M. Koval’zon, “The role of the histaminergic system of the brain in regulating the sleep–waking cycle,” Fiziol. Cheloveka, 39, No. 7, 13–23 (2013).PubMed 3.V. M. Koval’zon, “Central mechanisms of regulation of the sleep–waking cycle,” Fiziol. Cheloveka, 37, No. 4, 124–134 (2011).PubMed 4.V. M. Koval’zon and I. M. Zavalko, “The sleep–waking cycle and Parkinson’s disease,” Neirokhimiya, 30, No. 3, 193–207 (2013). 5.Yu. F. Pastukhov, “Changes in the characteristics of paradoxical sleep– an early sign of parkinsonism,” Zh. Vyssh. Nerv. Deyat., 73, No. 1, 75–85 (2013). 6.O. Sacks, Awakenings [Russian translation], Astrel, Moscow (2013). 7.C. Blanco-Centurion, D. Gerashchenko, and P. J. Shiromani, “Effects of saporin-induced lesions of three arousal populations on daily levels of sleep and wake,” J. Neurosci., 27, No. 51, 14041–14048 (2007).CrossRef PubMed PubMedCentral 8.K. Fifel, O. Dkhissi-Benyahya, and H. M. Cooper, “Lack of longterm changes in circadian, locomotor, and cognitive functions in acute and chronic MPTP (1.2.3.7-tetrahydropyridine) mouse models of Parkinson’s disease,” Chronobiol. Int., 30, No. 7, 741–755 (2013).CrossRef PubMed 9.A. Iranzo, “Sleep-wake changes in the premotor stage of Parkinson disease,” J. Neurol. Sci., 310, 283–285 (2011).CrossRef PubMed 10.C. Laloux, P. Derambure, J.-M. Jacquesson, et al., “The effects of serotoninergic, noradrenergic, cholinergic and dopaminergic drugs on vigilance states in MPTP-treated mice,” Brain Res., 117, 79–87 (2007).CrossRef 11.C. Laloux, P. Derambure, A. Kreisler, et al., “MPTP-treated mice: long-lasting loss of nigral TH-ir neurons but not paradoxical sleep alterations,” Exp. Brain Res., 187, 735–742 (2008). 12.W. Le, P. Sayana, and J. Jankovic, “Animal models of Parkinson’s disease: A gateway to therapeutics?” Neurotherapeutics, 11, 92–110 (2014).CrossRef PubMed PubMedCentral 13.M. S. M. Lima, “Sleep disturbances in Parkinson’s disease: The contribution of dopamine in REM sleep regulation,” Sleep Med. Rev., 17, No. 5, 377–375 (2012). 14.C. Monaca, C. Laloux, J.-M. Jacquesson, et al., “Vigilance states in a parkinsonian model, the MPTP mouse,” Eur. J. Neurosci., 20, No. 9, 2474–2478 (2004).CrossRef PubMed 15.J. Peever, P.-H. Luppi, and J. Montplaisir, “Breakdown in REM sleep circuitry underlies REM sleep behavior disorder,” Trends Neurosci., 37, No. 5, 279–288 (2014).CrossRef PubMed 16.I. Shpirer, A. Miniovitz, C. Klein, et al., “Excessive daytime sleepiness in patients with Parkinson’s disease: A polysomnography study,” Mov. Disord., 21, No. 9, 1432–1438 (2007).CrossRef 17.M. V. Ugrumov, V. G. Khaindrava, E. A. Kozina, et al., “Modeling of presymptomatic and symptomatic stages of parkinsonism in mice,” Neuroscience, 181, 175–188 (2011).CrossRef PubMed
作者单位:A. I. Manolov (1) V. V. Dolgikh (1) Yu. V. Ukraintseva (1) I. M. Zavalko (2) A. V. Revishchin (3) G. V. Pavlova (3) T. S. Pronina (4) M. V. Ugryumov (4) V. B. Dorokhov (1) V. M. Koval’zon (5)
1. Institute of Higher Nervous Activity and Neurophysiology, Russian Academy of Sciences, Moscow, Russia 2. Federal Medical-Biophysical Center, Federal Medical-Biological Agency, Moscow, Russia 3. Institute of Gene Biology, Russian Academy of Sciences, Moscow, Russia 4. Institute of Developmental Biology, Russian Academy of Sciences, Moscow, Russia 5. Institute of Ecological and Evolutionary Problems, Russian Academy of Sciences, Moscow, Russia
刊物类别:Biomedical and Life Sciences
刊物主题:Biomedicine Neurosciences Neurobiology Behavioural Sciences Russian Library of Science